Abstract
Structural modulation of a lead p53-activating anticancer molecule was performed, leading to the synthesis of new bioactive molecules. Activity against human colorectal cancer cells with different p53 status provided in-depth SAR data.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
